M&A – Mexico’s Rimsa for generic and in Emerging markets

Rimsa (Mexico City-based drugmker) drawing interest to the tune of $1 Billion for the company of generic-drugs. The spark is fueled by low rates of health-care spend for emerging markets – Brazil, Chile, etc. where paying for brand-name drugs is not the norm.  In the hunt is also Abbott, Teva, Pfizer, Sanofi, etc.  www.bloomberg.com